Female Infertility. Female infertility associated with anovulation
Conditions
Interventions
Intervention 1: The first intervention group: 20 infertile patients who were stimulated using the Gnrh agonist ampoule (Cinafact) of Cinagen Company, from the 21th day of previous cycle , 20 IU subcu
The eggs are aspirated from the follicular fluid and rinsed several times, then a drop of hyaluronidase is added to them and the cumulus is separated.Gene extract from Cumulus, At this stage, first R
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: The age of 20- 30 years old. Normal response to induction of ovulation.
Exclusion criteria
Exclusion criteria: unexplained infertility Cause Azoospermia Ovarian hyper stimulation Syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maturation of Oocyte. Timepoint: 36 hours after the last administration of treatment. Method of measurement: Electronic Microscope.;Fertilization rate. Timepoint: 24 hours after intra cytoplasmic sperm injection. Method of measurement: Electronic Microscope.;Rate of Embryo development. Timepoint: The third day of intra cytoplasmic sperm injection. Method of measurement: Electronic Microscope.;The evaluation of Gene expression of HAS-2, BAX, BCL-2, VCAN, ALCAM, R PTGS-2 in cumulus of oocyte. Timepoint: The day of pick up ovum. Method of measurement: Real time PCR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeed Azizollahi
Tehran University of Medical Sciences
Outcome results
None listed